Pharmacy Report Archives - Page 72 of 136 - Becker's Hospital Review

DOJ probes telehealth firm's prescribing practices | GoodRx names COO | Novartis pauses production of 2 drugs | Jha warns of 'pretty sizable' fall COVID wave | FDA limits use of J&J shot | 4 drug recalls

May 9, 2022 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. DOJ investigating telehealth startup after allegations of overprescribing stimulants Full story 2. Novartis suspends production of 2 cancer treatments over quality concerns Full story 3. FDA limits use of J&J…

FDA weighs in on 2nd Paxlovid course | Walgreens settles Fla. opioid suit for $683M | Viewpoint: Time to call a surge a surge | CVS' growing primary care footprint | 10 hospitals seeking pharmacy leaders | 4 drug approvals

May 5, 2022 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. FDA: 'No evidence' 2nd Paxlovid course stops recurring symptoms Full story 2. CVS reports 1.5M community health visits in Q1: 6 things to know Full story 3. Walgreens to…

Walgreens names 3 senior execs | FDA fast tracks Alzheimer's vaccine | 2nd Paxlovid course OK for rebounding symptoms: Pfizer | 7 hospitals laying off workers | Health plans grapple with specialty drug costs

May 4, 2022 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. Walgreens names 3 senior execs Full story 2. 2nd course of Paxlovid OK for rebounding symptoms, Pfizer says Full story 3. Pharmacies weigh offering COVID-19 shots for kids younger than 3 Full…

Amazon's PillPack to pay $5.8M for insulin overbilling | Biogen CEO to resign | FDA rejects 2 China-developed drugs | 22 hospitals with most ER visits | CVS Health names CMO | Paxlovid falls short as preventive therapy

May 3, 2022 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. Amazon's PillPack to pay $5.8M for insulin overbilling Full story 2. CVS Health names new chief medical officer, senior VP Full story 3. FDA declines to approve 2 cancer drugs developed…

5 reasons 'test to treat' is off to rocky start | Minn. seeks $1.25M fine against CVS Caremark | CMS' Medicare Part D final rule | A subdued COVID climb: What 4 experts make of it | DEA suspends Ill. pharmacy's license

May 2, 2022 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. 5 reasons 'test to treat' is off to a rocky start Full story 2. Minnesota seeking $1.25M fine against CVS Caremark over alleged unlawful PBM practices Full story 3. CMS…

Physicians wave red flag on automated pharmacy tech | Walmart, CVS block ADHD drug scripts from telehealth startups | Pandemic not over, Fauci clarifies | Moderna asks FDA to clear COVID shot for kids under 6

April 28, 2022 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. Walmart, CVS and others blocking ADHD drug prescriptions from online startups Full story 2. Physician leaders wave red flag on automated pharmacy technology Full story 3. Moderna asks FDA to authorize…

Repeat shots advised for 1,800 after pharmacy's storage error | Google invests $35M in pharmacy co. | Fauci: US out of 'pandemic phase' | Pharmacist gets prison time for $180M fraud scheme | Pfizer asks FDA to clear booster for kids 5-11

April 27, 2022 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. Pfizer asks FDA to authorize booster for kids 5-11 Full story 2. Mississippi pharmacist sentenced to 10 years in $180M fraud scheme Full story 3. Repeat shots advised for…

Remdesivir approved for young kids | COVID symptoms can rebound after Paxlovid, patients say | 150 top places to work in healthcare | US may waste millions of COVID shots | Kaiser: Booster protection against hospitalization wanes after 3 mos.

April 26, 2022 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. FDA approves 1st COVID-19 treatment for young children Full story 2. Millions of COVID-19 shots may go to waste in US Full story 3. WHO recommendations, rebound symptoms: 2 Paxlovid updates Full…

AMA, pharmacists butt heads on reimbursement bill | Blood pressure drug recalled over cancer risk | A crucial point missing from mask debates | US to push Paxlovid use as supplies ramp up | 15 best, worst job markets

April 25, 2022 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. Pfizer recalls blood pressure drug over cancer risk Full story 2. COVID-19 shots for kids under 5 may be available by June, officials say Full story 3. AMA, pharmacists butt…

Biden's drug control plan: 5 notes | CDC advisers mull booster strategy | Hospital pharmacy director charged in COVID fraud scheme | COVID admissions up in 20 states | 10 hospitals seeking pharmacy leaders

April 21, 2022 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. Biden's national drug control strategy: 5 notes Full story 2. Pharmacy director among 21 charged in $149M COVID-19 fraud schemes: Justice Department Full story 3. CDC advisers mull booster plan:…